These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 25311380
1. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus. Song JF, Wang T, Zhu J, Zhou XY, Lu Q, Guo H, Zhang F, Wang Y, Li W, Wang DD, Cui YW, Lv DM, Yin XX. Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380 [Abstract] [Full Text] [Related]
2. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients. Zhou X, Chen C, Yin D, Zhao F, Bao Z, Zhao Y, Wang X, Li W, Wang T, Jin Y, Lv D, Lu Q, Yin X. Intern Med; 2019 Aug 15; 58(16):2341-2347. PubMed ID: 31118371 [Abstract] [Full Text] [Related]
8. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Huang Q, Yin JY, Dai XP, Wu J, Chen X, Deng CS, Yu M, Gong ZC, Zhou HH, Liu ZQ. Eur J Clin Pharmacol; 2010 Dec 15; 66(12):1207-15. PubMed ID: 20809084 [Abstract] [Full Text] [Related]
9. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. Gong ZC, Huang Q, Dai XP, Lei GH, Lu HB, Yin JY, Xu XJ, Qu J, Pei Q, Dong M, Zhou BT, Shen J, Zhou G, Zhou HH, Liu ZQ. Br J Clin Pharmacol; 2012 Sep 15; 74(3):501-9. PubMed ID: 22296034 [Abstract] [Full Text] [Related]
10. Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus. Song J, Li N, Hu R, Yu Y, Xu K, Ling H, Lu Q, Yang T, Wang T, Yin X. Front Endocrinol (Lausanne); 2022 Sep 15; 13():949990. PubMed ID: 36051387 [Abstract] [Full Text] [Related]
13. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes. Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA. Eur J Endocrinol; 2008 Jan 15; 158(1):35-46. PubMed ID: 18166815 [Abstract] [Full Text] [Related]
15. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population. Ye HD, Li YR, Hong QX, Zhou AN, Zhao QL, Xu LM, Xu MQ, Xu XT, Tang LL, Dai DJ, Jiang DJ, Huang Y, Wang DW, Duan SW. Genet Mol Res; 2015 Jun 11; 14(2):6350-9. PubMed ID: 26125839 [Abstract] [Full Text] [Related]
16. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes. Yu M, Xu XJ, Yin JY, Wu J, Chen X, Gong ZC, Ren HY, Huang Q, Sheng FF, Zhou HH, Liu ZQ. Clin Pharmacol Ther; 2010 Mar 11; 87(3):330-5. PubMed ID: 20054294 [Abstract] [Full Text] [Related]
18. PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects. Huang Y, Nie S, Zhou S, Li K, Sun J, Zhao J, Fei B, Wang Z, Ye H, Hong Q, Gao X, Duan S. Biomed Pharmacother; 2015 Mar 11; 70():7-11. PubMed ID: 25776471 [Abstract] [Full Text] [Related]
19. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX, Bao YQ, Jia WP, Xiang KS. Acta Pharmacol Sin; 2008 Aug 11; 29(8):983-9. PubMed ID: 18664331 [Abstract] [Full Text] [Related]
20. A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese. Qin W, Zhang R, Hu C, Wang CR, Lu JY, Yu WH, Bao YQ, Xiang KS, International Type 2 Diabetes 1q Consortium, Jia WP. Acta Pharmacol Sin; 2010 Apr 11; 31(4):450-4. PubMed ID: 20305679 [Abstract] [Full Text] [Related] Page: [Next] [New Search]